{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:40:53Z","timestamp":1792741253776,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"51","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.vaccine.2019.09.076","type":"journal-article","created":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T17:22:17Z","timestamp":1571246537000},"page":"7482-7492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Efficacy, safety and immunogenicity of a pneumococcal protein-based vaccine co-administered with 13-valent pneumococcal conjugate vaccine against acute otitis media in young children: A phase IIb randomized study"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6051-1484","authenticated-orcid":false,"given":"Laura L.","family":"Hammitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Borys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Weatherholtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Novalene","family":"Goklish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence H.","family":"Moulton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Traskine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristien","family":"Swinnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathuram","family":"Santosham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.vaccine.2019.09.076_b0005","doi-asserted-by":"crossref","first-page":"e744","DOI":"10.1016\/S2214-109X(18)30247-X","article-title":"Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000\u201315","volume":"6","author":"Wahl","year":"2018","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2019.09.076_b0010","unstructured":"IVAC. VIEW-hub. 2017; http:\/\/view-hub.org\/. Accessed July 25, 2017."},{"issue":"11","key":"10.1016\/j.vaccine.2019.09.076_b0015","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1001\/archinte.1992.00400230087015","article-title":"High incidence rates of invasive pneumococcal disease in the White Mountain Apache population","volume":"152","author":"Cortese","year":"1992","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.vaccine.2019.09.076_b0020","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/infdis\/170.2.368","article-title":"The epidemiology of invasive pneumococcal disease in Alaska, 1986\u20131990\u2013ethnic differences and opportunities for prevention","volume":"170","author":"Davidson","year":"1994","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2019.09.076_b0025","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/aje\/kwh082","article-title":"Potential impact of conjugate pneumococcal vaccines on pediatric pneumococcal diseases","volume":"159","author":"O'Brien","year":"2004","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1016\/j.vaccine.2019.09.076_b0030","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1086\/381198","article-title":"Invasive pneumococcal disease among Navajo adults, 1989\u20131998","volume":"38","author":"Watt","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"38","key":"10.1016\/j.vaccine.2019.09.076_b0035","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.1016\/j.vaccine.2015.07.080","article-title":"Impact of the 13-valent pneumococcal conjugate vaccine (PCV13) on invasive pneumococcal disease and carriage in Alaska","volume":"33","author":"Bruce","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.09.076_b0040","series-title":"Impact of pneumococcal conjugate vaccines (PCV) on invasive pneumococcal disease among American Indians living on the Navajo reservation","author":"Weatherholtz","year":"2018"},{"issue":"9","key":"10.1016\/j.vaccine.2019.09.076_b0045","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1086\/651680","article-title":"Invasive pneumococcal disease a decade after pneumococcal conjugate vaccine use in an American Indian population at high risk for disease","volume":"50","author":"Weatherholtz","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"26","key":"10.1016\/j.vaccine.2019.09.076_b0050","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1016\/j.vaccine.2016.03.107","article-title":"Status of research and development of pediatric vaccines for Streptococcus pneumoniae","volume":"34","author":"Alderson","year":"2016","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2019.09.076_b0055","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1128\/IAI.01082-15","article-title":"The first histidine triad motif of PhtD Is critical for zinc homeostasis in Streptococcus pneumoniae","volume":"84","author":"Eijkelkamp","year":"2016","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2019.09.076_b0060","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1080\/21645515.2016.1234553","article-title":"Preclinical evaluation of a chemically detoxified pneumolysin as pneumococcal vaccine antigen","volume":"13","author":"Hermand","year":"2017","journal-title":"Hum Vaccin Immunother"},{"issue":"Pt 2","key":"10.1016\/j.vaccine.2019.09.076_b0065","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1099\/mic.0.042184-0","article-title":"Transcriptional regulation, occurrence and putative role of the Pht family of Streptococcus pneumoniae","volume":"157","author":"Rioux","year":"2011","journal-title":"Microbiology"},{"issue":"2","key":"10.1016\/j.vaccine.2019.09.076_b0070","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1128\/IAI.69.2.949-958.2001","article-title":"Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis","volume":"69","author":"Adamou","year":"2001","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2019.09.076_b0075","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1128\/IAI.62.12.5683-5688.1994","article-title":"Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae","volume":"62","author":"Alexander","year":"1994","journal-title":"Infect Immun"},{"issue":"38","key":"10.1016\/j.vaccine.2019.09.076_b0080","doi-asserted-by":"crossref","first-page":"6451","DOI":"10.1016\/j.vaccine.2011.01.085","article-title":"Combined protective effects of anti-PhtD and anti-pneumococcal polysaccharides","volume":"29","author":"Denoel","year":"2011","journal-title":"Vaccine"},{"issue":"33","key":"10.1016\/j.vaccine.2019.09.076_b0085","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.1016\/j.vaccine.2011.05.051","article-title":"A protein-based pneumococcal vaccine protects rhesus macaques from pneumonia after experimental infection with Streptococcus pneumoniae","volume":"29","author":"Denoel","year":"2011","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2019.09.076_b0090","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.1128\/IAI.02124-14","article-title":"Human antibodies to PhtD, PcpA, and Ply reduce adherence to human lung epithelial cells and murine nasopharyngeal colonization by Streptococcus pneumoniae","volume":"82","author":"Kaur","year":"2014","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2019.09.076_b0095","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/21645515.2015.1111496","article-title":"Reactogenicity, safety and immunogenicity of a protein-based pneumococcal vaccine in Gambian children aged 2\u20134 years: a phase II randomized study","volume":"12","author":"Odutola","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"19","key":"10.1016\/j.vaccine.2019.09.076_b0100","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1016\/j.vaccine.2017.03.071","article-title":"Efficacy of a novel, protein-based pneumococcal vaccine against nasopharyngeal carriage of Streptococcus pneumoniae in infants: A phase 2, randomized, controlled, observer-blind study","volume":"35","author":"Odutola","year":"2017","journal-title":"Vaccine"},{"issue":"25","key":"10.1016\/j.vaccine.2019.09.076_b0105","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1016\/j.vaccine.2014.03.066","article-title":"Safety and immunogenicity of an investigational vaccine containing two common pneumococcal proteins in toddlers: a phase II randomized clinical trial","volume":"32","author":"Prymula","year":"2014","journal-title":"Vaccine"},{"issue":"35 Pt B","key":"10.1016\/j.vaccine.2019.09.076_b0110","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.1016\/j.vaccine.2017.07.008","article-title":"Safety, reactogenicity and immunogenicity of two investigational pneumococcal protein-based vaccines: Results from a randomized phase II study in infants","volume":"35","author":"Prymula","year":"2017","journal-title":"Vaccine"},{"issue":"33","key":"10.1016\/j.vaccine.2019.09.076_b0115","first-page":"1128","article-title":"Prevention and control of influenza with vaccines: recommendations of the advisory committee on immunization practices (ACIP) 2011","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"10.1016\/j.vaccine.2019.09.076_b0120","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1542\/peds.113.5.1451","article-title":"Diagnosis and management of acute otitis media","volume":"113","author":"American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media","year":"2004","journal-title":"Pediatrics"},{"issue":"50","key":"10.1016\/j.vaccine.2019.09.076_b0125","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.1016\/j.vaccine.2014.02.052","article-title":"Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: a phase I\/II randomized clinical study","volume":"32","author":"Leroux-Roels","year":"2014","journal-title":"Vaccine"},{"issue":"9512","key":"10.1016\/j.vaccine.2019.09.076_b0130","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0140-6736(06)68304-9","article-title":"Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study","volume":"367","author":"Prymula","year":"2006","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2019.09.076_b0135","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/INF.0000000000001420","article-title":"Etiology of acute otitis media in children less than 5 years of age: a pooled analysis of 10 similarly designed observational studies","volume":"36","author":"Van Dyke","year":"2017","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.1016\/j.vaccine.2019.09.076_b0140","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/INF.0b013e3181c1bc48","article-title":"New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine","volume":"29","author":"Casey","year":"2010","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.vaccine.2019.09.076_b0145","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM200102083440602","article-title":"Efficacy of a pneumococcal conjugate vaccine against acute otitis media","volume":"344","author":"Eskola","year":"2001","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2019.09.076_b0150","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/INF.0b013e318159228f","article-title":"Randomized, controlled trial efficacy of pneumococcal conjugate vaccine against otitis media among Navajo and White Mountain Apache infants","volume":"27","author":"O'Brien","year":"2008","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.vaccine.2019.09.076_b0155","doi-asserted-by":"crossref","first-page":"e1001657","DOI":"10.1371\/journal.pmed.1001657","article-title":"Efficacy of pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: a double-blind randomized controlled trial","volume":"11","author":"Tregnaghi","year":"2014","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.vaccine.2019.09.076_b0160","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/(SICI)1097-0258(20000115)19:1<13::AID-SIM279>3.0.CO;2-5","article-title":"Survival analysis for recurrent event data: an application to childhood infectious diseases","volume":"19","author":"Kelly","year":"2000","journal-title":"Stat Med"},{"issue":"47","key":"10.1016\/j.vaccine.2019.09.076_b0165","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1016\/j.vaccine.2015.07.085","article-title":"Maternal antibodies and infant immune responses to vaccines","volume":"33","author":"Edwards","year":"2015","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2019.09.076_b0170","doi-asserted-by":"crossref","first-page":"180","DOI":"10.15585\/mmwr.mm6706a2","article-title":"Interim estimates of 2017\u201318 seasonal influenza vaccine effectiveness - United States, February 2018","volume":"67","author":"Flannery","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2019.09.076_b0175","first-page":"CD010089","article-title":"Influenza vaccines for preventing acute otitis media in infants and children","volume":"10","author":"Norhayati","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.vaccine.2019.09.076_b0180","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1128\/IAI.06348-11","article-title":"Neutralizing antibodies elicited by a novel detoxified pneumolysin derivative, PlyD1, provide protection against both pneumococcal infection and lung injury","volume":"80","author":"Salha","year":"2012","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2019.09.076_b0185","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/INF.0000000000001207","article-title":"Impact of the 13-valent pneumococcal conjugate vaccine on pneumococcal carriage among American Indians","volume":"35","author":"Grant","year":"2016","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"10.1016\/j.vaccine.2019.09.076_b0190","doi-asserted-by":"crossref","first-page":"e0185824","DOI":"10.1371\/journal.pone.0185824","article-title":"Kinetics of antibodies against pneumococcal proteins and their relationship to nasopharyngeal carriage in the first two months of life","volume":"12","author":"Mendy","year":"2017","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1016\/j.vaccine.2019.09.076_b0195","doi-asserted-by":"crossref","first-page":"487.e1","DOI":"10.1016\/j.cmi.2017.01.011","article-title":"Correlation of higher antibody levels to pneumococcal proteins with protection from pneumococcal acute otitis media but not protection from nasopharyngeal colonization in young children","volume":"23","author":"Xu","year":"2017","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.vaccine.2019.09.076_b0200","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.vaccine.2016.11.046","article-title":"Trivalent pneumococcal protein vaccine protects against experimental acute otitis media caused by Streptococcus pneumoniae in an infant murine model","volume":"35","author":"Xu","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.09.076_b0205","article-title":"Pneumococcal conjugate vaccines for preventing acute otitis media in children","volume":"5","author":"Fortanier","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.vaccine.2019.09.076_b0210","doi-asserted-by":"crossref","first-page":"e20170101","DOI":"10.1542\/peds.2017-0181","article-title":"Epidemiology of acute otitis media in the postpneumococcal conjugate vaccine era","volume":"140","author":"Kaur","year":"2017","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.vaccine.2019.09.076_b0215","doi-asserted-by":"crossref","first-page":"e0211712","DOI":"10.1371\/journal.pone.0211712","article-title":"Bacterial causes of otitis media with spontaneous perforation of the tympanic membrane in the era of 13 valent pneumococcal conjugate vaccine","volume":"14","author":"Levy","year":"2019","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.vaccine.2019.09.076_b0220","doi-asserted-by":"crossref","first-page":"e714","DOI":"10.1542\/peds.2008-2838","article-title":"Mastering diagnostic skills: enhancing proficiency in otitis media, a model for diagnostic skills training","volume":"124","author":"Kaleida","year":"2009","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.vaccine.2019.09.076_b0225","doi-asserted-by":"crossref","first-page":"e964","DOI":"10.1542\/peds.2012-3488","article-title":"The diagnosis and management of acute otitis media","volume":"131","author":"Lieberthal","year":"2013","journal-title":"Pediatrics"},{"issue":"18","key":"10.1016\/j.vaccine.2019.09.076_b0230","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1016\/j.vaccine.2012.02.023","article-title":"Vaccine candidates PhtD and PhtE of Streptococcus pneumoniae are adhesins that elicit functional antibodies in humans","volume":"30","author":"Khan","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2019.09.076_b0235","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s40136-017-0152-6","article-title":"Streptococcus pneumoniae otitis media pathogenesis and how it informs our understanding of vaccine strategies","volume":"5","author":"Bergenfelz","year":"2017","journal-title":"Curr Otorhinolaryngol Rep"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19313040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19313040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T19:11:25Z","timestamp":1664651485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19313040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":47,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0264410X19313040"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.09.076","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736779516.793573976","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy, safety and immunogenicity of a pneumococcal protein-based vaccine co-administered with 13-valent pneumococcal conjugate vaccine against acute otitis media in young children: A phase IIb randomized study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.09.076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}